Example: Heart Attack

Clinical Trials on Oligoastrocytoma

Total 96 results

NCT02530320

Completed

Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved

Conditions: Oligodendroglioma; Oligoastrocytoma
NCT01847235

Completed

Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial

Conditions: Anaplastic Oligodendroglioma; Anaplastic Oligoastrocytoma
NCT00362570

Completed

Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma

Conditions: Oligoastrocytoma, Mixed; Anaplastic Oligodendroglioma
NCT00795457

Completed

Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas

Conditions: Astrocytoma; Oligo-Astrocytoma; Glioma
NCT04755023

Completed

Primary Chemotherapy by BCNU-TMZ Combination in Newly Diagnosed Anaplastic Oligodendrocytic Tumors: Phase II Trial With Translational Molecular Analysis

Conditions: Oligodendroglioma; Oligoastrocytoma
NCT00303849

Recruiting

Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors

Conditions: Anaplastic Oligoastrocytoma; Anaplastic Oligodendroglioma; Mixed Glioma; Oligoastrocytoma
NCT00033280

Completed

Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas

Conditions: Brain and Central Nervous System Tumors
NCT02026271

Active, not recruiting

A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma

Conditions: Glioblastoma Multiforme; Anaplastic Oligoastrocytoma
NCT00089427

Completed

IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma

Conditions: Glioblastoma Multiforme; Anaplastic Astrocytoma; Oligoastrocytoma
NCT02903784

Completed

Neural Basis of Language Processing

Conditions: Oligoastrocytoma; Astrocytoma; Oligodendroglioma
NCT02800486

Recruiting

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

Conditions: Glioblastoma; Anaplastic Astrocytoma; Anaplastic Oligoastrocytoma; Glioma; Brain Neoplasm; Brain Cancer; Brain Tumor; Brain Tumor, Recurrent; Brain Neoplasm, Malignant
NCT03353896

Withdrawn

NovoTTF-200A Device in Treating Patients With Newly Diagnosed High Risk Oligodendroglioma

Conditions: Anaplastic Oligodendroglioma; Oligoastrocytoma; Oligodendroglioma
NCT01089244

Unknown status

FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma

Conditions: Astrocytoma; Oligoastrocytoma; Oligodendroglioma
NCT02209428

Unknown status

A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas

Conditions: Astrocytoma; Oligodendroglioma; Oligoastrocytoma
NCT00874861

Completed

HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas

Conditions: Astrocytoma; Oligoastrocytoma; Oligodendroglioma
NCT00897377

Terminated

Treatment Strategy for Low-grade Gliomas

Conditions: Astrocytomas; Oligodendrogliomas; Oligoastrocytoma
NCT00717210

Completed

Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide

Conditions: Anaplastic Astrocytoma; Oligodendroglioma; Oligoastrocytoma
NCT02629757

Recruiting

A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas

Conditions: Anaplastic Oligoastrocytoma; Anaplastic Astrocytoma; Glioblastoma
NCT01765088

Unknown status

A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas

Conditions: Anaplastic Oligoastrocytoma; Anaplastic Astrocytoma; Glioblastoma
NCT02795364

Unknown status

Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas

Conditions: Glioma; Anaplastic Oligoastrocytoma; Glioblastomas (GBM)
NCT01711580

Withdrawn

Re-irradiation of High Grade Gliomas: a Quality of Life Study

Conditions: Anaplastic Astrocytoma; Glioblastoma Multiforme; Anaplastic Oligoastrocytoma
NCT00400816

Completed

Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma

Conditions: Central Nervous System Tumors; Brain Tumor
NCT00389090

Terminated

A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma

Conditions: Glioma; Astrocytoma; Oligodendroglioma; Oligoastrocytoma
NCT00003372

Completed

Topotecan in Treating Patients With Recurrent Brain Tumors

Conditions: Brain and Central Nervous System Tumors
NCT00049127

Completed

Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor

Conditions: Adult Anaplastic Oligodendroglioma; Adult Mixed Glioma; Adult Oligodendroglioma; Recurrent Adult Brain Neoplasm